GnRH-a-based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial protocol

被引：1
|
作者：
Qian Liu [1 ]
Huimei Zhou [1 ]
Mei Yu [1 ]
Dongyan Cao [1 ]
Jiaxin Yang [1 ]
机构：
[1] Peking Union Medical College Hospital,Department of Obstetrics and Gynecology
[2] Peking Union Medical College,undefined
[3] Chinese Academy of Medical Sciences,undefined
[4] National Clinical Research Center for Obstetric and Gynecologic Diseases,undefined
来源：
Trials | / 25卷 / 1期
关键词：
Endometrial neoplasms; Endometrial hyperplasia; Fertility preservation; Progestins; Gonadotropin-releasing hormone; Pregnancy outcome;
D O I：
10.1186/s13063-024-08414-0
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 26 条
  • [1] GnRH-a based fertility-sparing treatment of atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EC) patients: a multicenter, open-label, randomized designed clinical trial
    Liu, Qian
    Cao, Dongyan
    Zhou, Huimei
    Yu, Mei
    Yang, Jiaxin
    Wang, Tao
    Wang, Yongxue
    Wang, Jinhui
    Peng, Peng
    Cheng, Ninghai
    Shen, Keng
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_3) : A18 - A18
  • [2] A practical guideline on the fertility-sparing treatment of patients with endometrial carcinoma and atypical endometrial hyperplasia
    Catena, Ursula
    Macklon, Kirsten Louise Tryde
    Rodolakis, Alexandros
    Scambia, Giovanni
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025,
  • [3] The fertility-sparing treatment in patients with endometrial atypical hyperplasia and early endometrial cancer: A debated therapeutic option
    Gadducci, Angiolo
    Spirito, Nicoletta
    Baroni, Elena
    Tana, Roberta
    Genazzani, Andrea Riccardo
    GYNECOLOGICAL ENDOCRINOLOGY, 2009, 25 (10) : 683 - 691
  • [4] Diagnostic significance and predictive efficiency of metabolic risk score for fertility-sparing treatment in patients with atypical endometrial hyperplasia and early endometrial carcinoma
    Li, Xingchen
    Wang, Yiqin
    Wang, Jiaqi
    Zhou, Jingyi
    Wang, Jianliu
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (04)
  • [5] Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
    Ding, Yingqiao
    Fan, Yuan
    Li, Xingchen
    Wang, Yiqin
    Wang, Jianliu
    Tian, Li
    REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2022, 20 (01)
  • [6] Metabolic syndrome is an independent risk factor for time to complete remission of fertility-sparing treatment in atypical endometrial hyperplasia and early endometrial carcinoma patients
    Yingqiao Ding
    Yuan Fan
    Xingchen Li
    Yiqin Wang
    Jianliu Wang
    Li Tian
    Reproductive Biology and Endocrinology, 20
  • [7] Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women
    Ushijima, Kimio
    Yahata, Hideaki
    Yoshikawa, Hiroyuki
    Konishi, Ikuo
    Yasugi, Toshiharu
    Saito, Toshiaki
    Nakanishi, Toru
    Sasaki, Hiroshi
    Saji, Fumitaka
    Iwasaka, Tsuyoshi
    Hatae, Masayuki
    Kodama, Shoji
    Saito, Tsuyoshi
    Terakawa, Naoki
    Yaegashi, Nobuo
    Hiura, Masamichi
    Sakamoto, Atsuhiko
    Tsuda, Hitoshi
    Fukunaga, Masaharu
    Kamura, Toshiharu
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (19) : 2798 - 2803
  • [8] Analysis of assisted reproductive outcomes in patients with atypical endometrial hyperplasia and early-stage endometrial cancer after fertility-sparing treatment
    Li, Jiaheng
    Li, Mengnuo
    Li, Yijiang
    Zhao, Xianling
    Guan, Yichun
    Yuan, Xiaoqiong
    Du, Shanshan
    Zhang, Caihua
    Liu, Wenxia
    Ren, Bingnan
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2025, 168 (02) : 598 - 604
  • [9] Medroxyprogesterone acetate plus metformin for fertility-sparing treatment of atypical endometrial hyperplasia and endometrial carcinoma: trial protocol for a prospective, randomised, open, blinded-endpoint design, dose-response trial (FELICIA trial)
    Mitsuhashi, Akira
    Kawasaki, Yohei
    Hori, Makoto
    Fujiwara, Tadami
    Hanaoka, Hideki
    Shozu, Makio
    BMJ OPEN, 2020, 10 (02):
  • [10] EFFECT OF MEGESTROL ACETATE PLUS METFORMIN AS FERTILITY-SPARING TREATMENT FOR PATIENTS WITH ATYPICAL ENDOMETRIAL HYPERPLASIA AND WELL-DIFFERENTIATED ENDOMETRIAL CANCER. A RANDOMIZED CONTROLLED TRIAL
    Yang, B.
    Yierfulati, G.
    Guan, J.
    Chen, X.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A4 - A5
123